Schering Vanceril phase-out
Schering-Plough completely discontinues Vanceril with phase-out of 42 mcg strength, company says. Vanceril (beclomethasone) 84 mcg was previously discontinued as part of Schering's consent decree with FDA (1"The Pink Sheet" May 27, p. 13). The lower strength of the asthma drug had been on back-order for some time, Schering said. Vanceril generated $82 mil. in sales in 2001...
You may also be interested in...
Ivax will have 200 sales reps to promote Qvar and its other respiratory products by the end of the year, President Neil Flanzraich said in Ivax's third quarter conference call Oct. 29
Schering-Plough's Rebetol (ribavirin capsules) is the only oral product deemed "medically necessary" under the company's consent decree with FDA
The USP’s general chapter on nitrosamine impurities provides guidance on assessing risks and testing levels of the carcinogens in pharmaceuticals.